MAM
Mindshare names Sidharth Parashar as chief investment officer of APAC
MUMBAI: Mindshare, the media services company that is part of WPP, has appointed Sidharth Parashar as the chief investment officer of Mindshare APAC. Formerly the president of investments & pricing at GroupM India, Sidharth will be based in Singapore and will be part of the Mindshare APAC leadership team.
Reporting to Mindshare APAC chief executive officer Helen McRae, Sidharth will focus on enhancing Mindshare’s investment strategy across local markets as well as driving Intentional Investment and the opportunity for Good Growth in the region.
Helen McRae said, “I am very pleased that Sidharth will be joining our regional team. He brings a tremendous depth of expertise and will be a great champion of Good Growth for our clients.”
Commenting on his move from GroupM to Mindshare, GroupM South Asia CEO Prasanth Kumar said, “Sidharth has had a phenomenal career journey where the organisation has witnessed his evolution from a practice expert to a leader in the last 18 years with GroupM. He has successfully led the investment mandates across all media and has elevated the practice through innovative products and delivering exceptional value for our clients. I would like to wish him the very best and will continue to work closely with him as he drives the regional investment strategy for Mindshare.”
Parashar said, “It has been an amazing journey at GroupM, and I am delighted to now take over this new Mindshare APAC investments role. I look forward to this opportunity in new markets to build value for our client’s business.”
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
